Unprecedented gains have been made in the cure rates for childhoodcancer during the past four decades. This progress reflectssteady improvement in treatment protocols, a multidisciplinaryapproach to patient care, adequate hospital infrastructure,and psychosocial and economic support for affected families.Perhaps the greatest success has been the 80 percent cure rateamong children with acute lymphoblastic leukemia who are treatedin a modern center. Most of these survivors have long, productivelives, are well integrated into their communities, and makesubstantial contributions to society.1 But this story of medicalachievement is tempered by the harsh reality that more . . . [Full Text of this Article]
Source Information
Dr. Ribeiro is director of the International Outreach Program and Dr. Pui is director of the Leukemia/Lymphoma Division at St. Jude Children's Research Hospital in Memphis, Tenn. Dr. Pui is also a clinical research professor at the American Cancer Society.
Cancer in Developing Countries: The Great Challenge for Oncology in the 21st Century, edited by S. Tanneberger, F. Cavalli, and F. Pannuti, was published by Zuckschwerdt, Munich, 2004.
This article has been cited by other articles:
Sitaresmi, M. N., Mostert, S., Purwanto, I., Gundy, C. M., Sutaryo, , Veerman, A. J. P.
(2009). Chemotherapy-Related Side Effects in Childhood Acute Lymphoblastic Leukemia in Indonesia: Parental Perceptions. Journal of Pediatric Oncology Nursing
26: 198-207
[Abstract]
Ribeiro, R. C., Howard, S. C.
(2009). Sustainable Improvement of Pediatric Cancer Care in Low- and Middle-income Countries: The Experience of the St. Jude International Outreach Program. Am Soc Clin Oncol Ed Book
2009: 197-202
[Abstract][Full Text]
Coustan-Smith, E., Ribeiro, R. C., Stow, P., Zhou, Y., Pui, C.-H., Rivera, G. K., Pedrosa, F., Campana, D.
(2006). A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood
108: 97-102
[Abstract][Full Text]